Exact Sciences Cor (EXAS)
$46.81
0.00 (0.00%)
EXAS Stock Quote Delayed 30 Minutes
The 3 Best Personalized Medicine Stocks to Buy in July 2024
Explore promising personalized medicine stocks poised for growth as the industry expands, driven by advancements in genomic technologies.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
8.05B
PE Ratio
-41.06
EPS
-1.14
Volume (Avg. Vol.)
11
Day's Range
-
52-Week Range
$40.62 - $99.56
Dividend & Yield
N/A (N/A)
EXAS Stock Predictions, Articles, and Exact Sciences Cor News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
EXAS Stock Earnings: Exact Sciences Misses EPS, Beats Revenue for Q1 2024
EXAS stock results show that Exact Sciences missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
7 Very Oversold Nasdaq Stocks to Buy Right Now
The worries that have pushed the Nasdaq down sharply are overdone. Here are seven oversold Nasdaq stocks poised to rebound.
